TeselaGen Company

TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants. Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.
Technology: Artificial Intelligence, Biotechnology, Genetics, Information Technology, Life Science, Software
Industry: Early Drug Development
Headquarters: San Francisco, California, United States
Founded Date: 2011-06-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 3
Total Funding: 3250000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-10-14
Last Funding Type: Seed

Visit Website
mike.fero@teselagen.com
http://twitter.com/teselagen
Register and Claim Ownership